Page last updated: 2024-11-05

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Chronic Disease

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Chronic Disease in 1 studies

N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhao, L1
Liu, Q1
Ma, S1
Zhang, Y1
Liang, P1

Other Studies

1 other study available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Chronic Disease

ArticleYear
TPEN Attenuates Neural Autophagy Induced by Synaptically-released Zinc Translocation and Improves Histological Outcomes after Traumatic Brain Injury in Rats.
    Annals of clinical and laboratory science, 2018, Volume: 48, Issue:4

    Topics: Animals; Autophagy; Beclin-1; Brain Injuries, Traumatic; Chelating Agents; Chronic Disease; Constric

2018